<DOC>
	<DOCNO>NCT02471378</DOCNO>
	<brief_summary>Background : - Malaria disease affect many people African country . It cause germ spread mosquito bite . It fatal diagnose treated right away . Children young 5 pregnant woman risk get malaria . Researchers want create vaccine prevent malaria infection pregnancy . Objectives : - To create vaccine prevent malaria infection pregnancy . To assess possible vaccine use in-vitro test parasites take pregnant woman . Eligibility : - Pregnant woman age 15 25 Design : - The study site area Mali , West Africa . - Participants : - Will blood drawn . - Will give consent blood sample use future research . - May physical exam . - Participants malaria anemia get treatment .</brief_summary>
	<brief_title>Laboratory Evaluation Pregnancy Malaria Vaccine Candidates/In-vitro Testing Pregnancy Malaria Vaccine Candidates</brief_title>
	<detailed_description>Malaria cause Plasmodium falciparum continue global problem devastate consequence . Pregnancy malaria associate low birth weight ( LBW ) , maternal anemia , gestational hypertension ; inflammation fetal response infection may contribute poor outcome . Pregnancy malaria ( PM ) cause P. falciparum-infected erythrocyte bind placental receptor chondroitin sulfate A ( CSA ) sequester placenta , cause disease death mother offspring . Women become resistant pregnancy malaria acquire antibody target surface protein placental parasite . Malaria vaccine candidate target parasite liver stage blood stage may protect pregnant woman unborn child . The primary hypothesis study antibody raise animal recombinant pregnancy malaria vaccine candidate similar functional activity naturally acquire antibody . Up 486 malaria-infected pregnant woman recruit cross sectional study conduct Ouelessebougou neighbor district , Mali . Women present antenatal visit health center Ouelessebougou District enrol . Samples collect woman use in-vitro assay assess functional activity immunoglobulin G ( IgG ) raise pregnancy malaria vaccine candidate primary outcome study . For secondary outcome , examine functional activity naturally acquire antibody specific vaccine candidate . Functional activity IgG vaccine candidate compare activity obtain control proteins use appropriate statistical method , include adjustment possible confounders parasite density assay , determine candidate elicit type immune response observe naturally expose population .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>INCLUSION CRITERIA : A study participant must satisfy follow criterion enrol study : Pregnant woman age 1525 year Able provide consent self Malaria positive rapid diagnostic test ( RDT ) EXCLUSION CRITERIA : Severe anemia define HGB &lt; 7 gr/dL , may worsen 10 mL phlebotomy Conditions judgment investigator could increase risk volunteer Prior enrollment study pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>June 2, 2016</verification_date>
	<keyword>Assay</keyword>
	<keyword>Women</keyword>
	<keyword>Infected</keyword>
	<keyword>Antibodies</keyword>
</DOC>